Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years

Journal:

The Journal of Allergy and Clinical Immunology

Published:

2026-04-14

DOI:

10.1016/j.jaci.2026.04.001

Affiliations:

38

Authors:

38

Go to article

Institutions	Authors	Share
Blueprint Medicines, United States of America (USA)	5.000000	0.13
Stanford University School of Medicine, United States of America (USA)	2.000000	0.05
Brigham and Women's Hospital (BWH), United States of America (USA)	2.000000	0.05
University of Michigan (U-M), United States of America (USA)	1.000000	0.03
Antwerp University Hospital (UZA), UA, Belgium	1.000000	0.03
Institute for the Study of Mastocytosis of Castilla La Mancha (CLMast), Spain	1.000000	0.03
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)	1.000000	0.03
Toulouse University Hospital (CHU-Toulouse), France	1.000000	0.03
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	1.000000	0.03
University Medical Center Groningen (UMCG), RUG, Netherlands	1.000000	0.03
Erasmus University Medical Center (Erasmus MC), Netherlands	1.000000	0.03
University of Calgary (U of C), Canada	1.000000	0.03
UiO Rikshospitalet, Norway	1.000000	0.03
University Medical Centre Mannheim (UMM) at Medical Faculty Mannheim, Uni Heidelberg, Germany	1.000000	0.03
Mayo Clinic, United States of America (USA)	1.000000	0.03
AP-HP Pitié-Salpêtrière Hospital, France	1.000000	0.03
Rush University, United States of America (USA)	1.000000	0.03
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany	1.000000	0.03
St. Michael's Hospital, Canada	1.000000	0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.03
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.03
Duke University, United States of America (USA)	1.000000	0.03
The University of Alabama at Birmingham (UAB), United States of America (USA)	1.000000	0.03
University of Salerno (UNISA), Italy	1.000000	0.03
University Hospital of Verona, Italy	1.000000	0.03
University Hospital Basel (USB), UB, Switzerland	1.000000	0.03
Odense University Hospital (OUH), Denmark	1.000000	0.03
Uppsala University Hospital, Sweden	1.000000	0.03
The University of Utah (Utah), United States of America (USA)	1.000000	0.03
Huntsman Cancer Institute at the University of Utah (HCI), Utah, United States of America (USA)	1.000000	0.03
University Hospital Aachen (UKA), RWTH Aachen, Germany	0.500000	0.01
Center for Integrated Oncology Aachen Bonn Köln Düsseldorf (CIO), Germany	0.500000	0.01
Charité - University Medicine Berlin, Germany	0.500000	0.01
Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Germany	0.500000	0.01

Interested in Cardiovascular Medicine and Haematology?